DENND1A and polycystic ovary syndrome: For instance, CRISPR can be used to edit the reproductive gene DENND1A, which is associated with androgen biosynthesis and elevated testosterone levels, while also targeting a metabolic gene, such as IRS1, which plays a role in insulin signaling and has been found to be impaired in PCOS patients [177,178].